Phase 2 Melanoma (Skin Cancer) trials recruiting now

All Melanoma (Skin Cancer) trials, every phase

Other phases for Melanoma (Skin Cancer)

Phase 2 Melanoma (Skin Cancer) trials

• A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.
  NCT07448831 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
  NCT06624644 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
  NCT07410494 · Phase: Phase 1, Phase 2 · Ages: 8 Years to 85 Years · Sex: All (male and female) · 3 locations
• Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.
  NCT07686835 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
  NCT07410676 · Phase: Phase 1, Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
  NCT07718243 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
  NCT07349303 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SL-28 for Advanced Solid Tumours
  NCT07341737 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
  NCT07287917 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.